Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Cochlear | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
The study is about the importance of each follow-up visit after activating a new cochlear implant in addition to evaluating the effectiveness and efficiency of a new programming strategy from Cochlear Americas. Investigators are looking for patients who have recently selected Cochlear Americas as their cochlear implant manufacturer of choice for their upcoming surgery. The aim of this study is to determine if 1) patient outcomes remain stable when reducing follow-up appointments and 2) Cochlear's population mean mapping can produce similar outcomes with patients while additionally reducing appointment times. The hypothesis is that using population mean mapping and reducing the number of follow-up visits after activation will yield similar performance outcomes to a standard of care while decreasing the length of appointment times and number of appointments needed for each patient.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Population mean mapping, without 1 week follow-up | Experimental | Reduction in the number of follow-up visits and new programming strategy. |
|
| Population mean mapping, traditional follow-up | Experimental | New programming strategy |
|
| Traditional mapping*, without 1 week follow-up | Experimental | Reduction in the number of follow-up visits. |
|
| Traditional mapping, traditional follow-up | No Intervention | Traditional follow-up plan |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Changes in traditional follow-up | Other | Traditional follow-up includes the following visits after activation: 1-week, 1-month, 3-months, 6-months and 1 year. With the intervention used, the 1-week follow-up is removed. |
| Measure | Description | Time Frame |
|---|---|---|
| Speech perception scores | Speech perception scores via CNC word lists (percentages) at each visit. Scores are from 0 to 100% with 100% being the best. | 1-year |
| Duration of programming session | Time spent programming (seconds) at each visit | 1-year |
| Measure | Description | Time Frame |
|---|---|---|
| Quality of Life questionnaire | Patient outcomes via the Cochlear Implant Quality of Life-35 Profile questionnaire at each visit. Scores are out of 35 points and higher scores indicate better quality of life. | 1-year |
| Soundfield detection thresholds |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Arenberg | Contact | 6178077904 | julie_arenberg@meei.harvard.edu |
| Name | Affiliation | Role |
|---|---|---|
| Julie Arenberg | Massachusetts Eye and Ear | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Mass Eye and Ear | Recruiting | Boston | Massachusetts | 02114 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Population mean mapping | Other | Traditional mapping at activation involves the measurement of at least 5 electrodes (both T-levels and C-levels). The intervention uses a population mean mapping strategy where there is a pre-set dynamic range of 46 CL with a spot check of C-levels. |
|
Change in soundfield detection thresholds (dB HL) between each visit. Detection thresholds should be between 20 and 35 dB HL and anywhere in that range is good.
| 1-year |
| programming levels | Change in programming levels between each visit (converted measure from CL to charge units). There is no indication of good and bad with programming levels, we are just measuring what they are and how stable they are over time. | 1-year |
| ID | Term |
|---|---|
| D003638 | Deafness |
| D006319 | Hearing Loss, Sensorineural |
| ID | Term |
|---|---|
| D034381 | Hearing Loss |
| D006311 | Hearing Disorders |
| D004427 | Ear Diseases |
| D010038 | Otorhinolaryngologic Diseases |
| D012678 | Sensation Disorders |
| D009461 | Neurologic Manifestations |
| D009422 | Nervous System Diseases |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided